8 stories tagged "regulatory-capture"
The Trump administration on Thursday proposed closing the product-hopping loophole that lets drugmakers reset Medicare's negotiation clock by tweaking inactive ingredients. It is the same fix the same administration quietly tabled in October.
Drugs & FDAA new chemical UV filter Europe approved in 1999 just cleared the FDA after a 21-year wait, while Americans relied on ingredients the agency's own 2019 review could not call safe.
Brain & Aging54,804 Danes followed for a quarter-century: less dementia from vegetable nitrate, more from drinking water. The risk signal shows up at roughly one-ninth of what the US EPA still permits.
Infectious DiseaseCambridge finished the Phase 1 trial in 2023. The press tour arrived in 2026. The paper, when you read it, said the immunogenicity was modest.
CancerAn oncologist's bedside pattern, a Senate hearing, and a mechanism paper sitting in a mainstream oncology journal: the case that repeated mRNA boosters may be lifting the brakes off cancers oncologists thought they had quiet is no longer fringe enough to wave away.
InvestigationsA Senate Homeland Security subcommittee took testimony on whether mRNA COVID shots can plausibly cause cancer, and on the parallel campaign to keep that question out of the journals. Dr. John Campbell walked his audience through it.
InvestigationsA federal grand jury in the Eastern District of Kentucky indicted the founder of Addiction Recovery Care on June 4 for selling the same COVID-era tax credit twice. The bigger case, the FBI Medicaid investigation into the company he built, is still open.
Drugs & FDAFDA's new gene therapy draft guidance invites sponsors to lean on "platform knowledge" to streamline submissions, six months after the agency revoked Sarepta's AAVrh74 platform designation following three patient deaths.